Lipid and pleiotropic effects of atorvastatin in patients with acute coronary syndrome

Lipid and pleiotropic effects of atorvastatin in patients with acute coronary syndrome

Aim. To study the effects of an HMG-CoA reductase inhibitor atorvastatin in patients with acute coronary syndrome (ACS).Material and methods. The study included 116 ACS patients, divided into two comparable groups. Total follow-up time was 180±7 days.Results. In 6 months of the follow-up, the patien...

Full description

Bibliographic Details
Main Authors:	A. A. Yalymov, G G Shekhyan, A. A. Bylyeva, V. S. Zadionchenko
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 1970-01-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	hmg-coa reductase inhibitor atorvastatin acute coronary syndrome microcirculation central hemodynamics endothelial dysfunction reology
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1609

Similar Items

Synthesis of New Atorvastatin Derivatives and Assessing Their Effect on Liver and Kidney Serum Parameters, Function, and Histology in Rabbits
by: Shiva Najafi, et al.
Published: (2023-08-01)

The effect of the various doses of atorvastatin on renal tubular cells; an experimental study
by: Hamid Nasri, et al.
Published: (2016-07-01)

Frameshift variation in the HMG-CoA reductase gene and unresponsiveness to cholesterol-lowering drugs in type 2 diabetes mellitus patients
by: Esmat Khaleqsefat, et al.
Published: (2025-01-01)

Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity
by: Gene C. Ness, et al.
Published: (1998-01-01)

Development and validation of a simple method for the determination of Atorvastatin calcium in pure and pharmaceutical formulations using spectrofluorimetry
by: Nisreen Ahmad, et al.
Published: (2023-03-01)

Evaluation of Atorvastatin Safety on Liver Function Tests, a Prospective Study
by: Ramin Talaie, et al.
Published: (2015-07-01)

Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin
by: Lisa J. Wilcox, et al.
Published: (1999-06-01)

Modern algorithms for statin therapy
by: V. A. Susekov
Published: (2023-11-01)

Comparative efficacy and safety among high-intensity statins. Systematic Review and Meta-Analysis
by: Myriam Jaam, et al.
Published: (2023-02-01)

Antihyperlipidemic studies of newly synthesized phenolic derivatives: in silico and in vivo approaches
by: Aqeel MT, et al.
Published: (2018-08-01)

Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test
by: Dick C. Chan, et al.
Published: (2002-05-01)

Beneficial Effects of Statins on Seizures Independent of Their Lipid-Lowering Effect: A Narrative Review
by: Arash Amanlou, et al.
Published: (2023-01-01)

Effect of Diallyl Disulphide on Diabetes Induced Dyslipidemia in Male Albino Rats
by: Naveen Kumar Sambu, et al.
Published: (2015-04-01)

Atorvastatin for reduction of 28-day mortality in hospitalized COVID-19 patients: study protocol for a randomized, double-blinded, placebo-controlled, clinical trial
by: Moataz Maher Emara, et al.
Published: (2022-08-01)

Pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteers
by: Choi Y, et al.
Published: (2018-07-01)

Impact of matrix metalloproteinase 9 rs3918242 genetic variant on lipid-lowering efficacy of simvastatin therapy in Chinese patients with coronary heart disease
by: Yuanyuan Xu, et al.
Published: (2017-04-01)

Are statins toxic or safe for kidney diseases? An updated mini-review study
by: Shadi Botshekan, et al.
Published: (2020-10-01)

Hesperidin Interaction with HMG-CoA-Reductase Enzyme in Hypercholesterolemia: A Study in Silico
by: Annisa Rizqi Dwi Oktaviani, et al.
Published: (2021-09-01)

Single dose testosterone increases total cholesterol levels and induces the expression of HMG CoA Reductase
by: Gårevik Nina, et al.
Published: (2012-03-01)

Isolation and purification of 3-hydroxy-3-methylglutaryl-coenzyme A by ion-exchange chromatography
by: I P Williamson, et al.
Published: (1981-01-01)

The quantitative assay of 3-hydroxy-3-methylglutaryl coenzyme A reductase: comparison of a thin-layer chromatographic assay with a rapid chloroform extraction assay
by: M E Ackerman, et al.
Published: (1977-05-01)

Atorvastatin for reduction of 28-day mortality in severe and critical COVID-19 patients: a randomized controlled trial
by: Naglaa Hamdi Eltahan, et al.
Published: (2024-02-01)

7-Dehydrocholesterol down-regulates cholesterol biosynthesis in cultured Smith-Lemli-Opitz syndrome skin fibroblasts
by: Megumi Honda, et al.
Published: (1998-03-01)

ENDOTHELIUM AND CARDIOPROTECTIVE EFFECTS OF HMG-CO-A-REDUCTASE IN COMBINATION WITH L-ARGININE IN ENDOTHELIAL DYSFUNCTION MODELING
by: Tatiana Denisyuk, et al.
Published: (2016-03-01)

3-Hydroxy-3-methylglutaryl coenzyme A reductase in isolated villous and crypt cells of the rat ileum
by: J L Merchant, et al.
Published: (1977-11-01)

Efficacy of Generic Atorvastatin in a Real-World Setting
by: Manasirisuk P, et al.
Published: (2021-03-01)

The sterol response element binding protein regulates cyclooxygenase-2 gene expression in endothelial cells
by: Layton Harris Smith, et al.
Published: (2005-05-01)

Antihyperlipidemic Activity of Hydroxyl Methylglutaryl Coenzyme A Reductase Inhibitor on Lipid Profile in Secondary Hyperlipidemia
by: Naveed Ali Siddiqui, et al.
Published: (2020-09-01)

The Potency of Water Clover (<I>Marsilea crenata</I> C. Presl.) Leaves as Anticholesterolemic Functional Foods Through <I>In Silico</I> Study
by: Hardoko Hardoko, et al.
Published: (2023-01-01)

Statins in clinical medicine
by: Swiss Medical Weekly
Published: (2011-11-01)

Statins and its Effects on Lipids and Glycemic Status: A Quasi-Experimental Study
by: Sikandar Hayat Khan, et al.
Published: (2024-04-01)

Effects of atrovastatin on concentrations of 3-hydroxy-3-methylglutaryl-coenzyme A- reductase (HMG-CoA-R), proprotein convertase subtilisin/kexin type 9 (PCSK9) and sortilin in patients with type 2 diabetes mellitus and pre-diabetics
by: Ali Nosrati Andevari, et al.
Published: (2021-01-01)

Parallel regulation of sterol regulatory element binding protein-2 and the enzymes of cholesterol and fatty acid synthesis but not ceramide synthesis in cultured human keratinocytes and murine epidermis
by: Ian R. Harris, et al.
Published: (1998-02-01)

Pleiotropic Effects of Atorvastatin Result in a Downregulation of the Carboxypeptidase U System (CPU, TAFIa, CPB2) in a Mouse Model of Advanced Atherosclerosis
by: Karen Claesen, et al.
Published: (2021-10-01)

Cholesterol and sphingomyelin syntheses are regulated independently in cultured human intestinal cells, CaCo-2: role of membrane cholesterol and sphingomyelin content.
by: Heshun Chen, et al.
Published: (1993-12-01)

A systematic review and meta-analysis of the effect of statins on osteoporotic fractures
by: Shahin Asgari-Savadjani, et al.
Published: (2024-06-01)

Gene expression of sterol regulatory element-binding proteins in hamster small intestine
by: F. Jeffrey Field, et al.
Published: (2001-01-01)

Effects of amlodipine and atorvastatin on endothelial vasoactive mediators in patients with metabolic syndrome
by: N V Blinova, et al.
Published: (2015-03-01)

Liver biochemistry abnormalities in a quaternary care lipid clinic database
by: Holly A.R. Wiesinger, et al.
Published: (2008-01-01)

Does atorvastatin work more effectively than biguanides in reducing cardiovascular risk factors?
by: Afshan Siddiq, et al.
Published: (2011-01-01)